Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00610
|
|||||
| Drug Name |
Pindolol
|
|||||
| Synonyms |
(+-)-Pindolol; (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol; 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol; 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol; 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol; 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol; 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol; 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol; 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol; 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol; 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol; 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole; 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole; Betapindol; Betapindol (TN); Blockin L; Blockin L (TN); Blocklin; Blocklin L; Blocklin L (TN); Blocklin-L; Blocklin-L (TN); Calvisken; Calvisken (TN); Cardilate (TN); Carvisken; Carvisken (TN); DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; DL-LB 46; DL-Pindolol; Decreten; Decreten (TN); Durapindol; Durapindol (TN); Glauco-Visken (TN); Glauco-Viskin; Glauco-visken; LB 46; LB-46; LB46; P 0778; P-6820; Pectobloc; Pectobloc (TN); Pinbetol; Pinbetol (TN); Pindolol (JP15/USP/INN); Pindolol [USAN:INN:BAN:JAN]; Pindololum; Pindololum [INN-Latin]; Prindolol; Prindolol (TN); Prinodolol; Pynastin; Pynastin (TN); Visken; Visken (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H20N2O2
|
|||||
| Canonical SMILES |
CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
|
|||||
| InChI |
InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3/t11-/m0/s1
|
|||||
| InChIKey |
JZQKKSLKJUAGIC-NSHDSACASA-N
|
|||||
| CAS Number |
CAS 13523-86-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 248.32 | Topological Polar Surface Area | 57.3 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
1.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103340603
, 103966357
, 109890703
, 11113889
, 121361223
, 124749642
, 124799687
, 128350665
, 135650828
, 135697987
, 137149274
, 14798566
, 14798567
, 162022836
, 162247517
, 163127011
, 163564303
, 17404912
, 17405585
, 175270310
, 179149848
, 196369461
, 226396988
, 241182092
, 241375191
, 24278026
, 26732601
, 26752052
, 44871985
, 46530676
, 48169371
, 48256917
, 48318405
, 48393931
, 50104702
, 50104703
, 50661418
, 53777455
, 53778133
, 57408548
, 85787587
, 90341477
, 91721940
, 92303745
, 9286447
|
|||||
| ChEBI ID |
ChEBI:8214
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.